Literature DB >> 8953519

Immunization against exon 1 decapeptides from the lutropin/choriogonadotropin receptor or the follitropin receptor as potential male contraceptive.

J J Remy1, L Couture, H Rabesona, T Haertle, R Salesse.   

Abstract

Pituitary gonadotropin hormones lutropin (LH) and follitropin (FSH) control steroidogenesis and gametogenesis in male and female gonads through interaction with G protein-coupled receptors, LHR and FSHR. In the male, LH acts on leydig cells and is mostly responsible for the acquisition of puberty and the production of androgens while FSH, together with androgens, regulates spermatogenesis within Sertoli cells. We have engineered filamentous phages displaying mouse LHR and human FSHR decapeptides chosen in hormone binding regions. Peptides from both receptors displayed on phages belong either to the receptor specific exon 1 (amino acids 18-27) or to the homologous exon 4 (amino acids 98-107). Vaccination of prepubertal BALB/c male mice with hybrid phages using sub-cutaneous or intraperitoneal injections induced immunity against receptors. Anti-receptor immunization produced agonist or antagonist effects depending only on the circulating levels of the antibodies. Both anti-LHR and anti-FSHR vaccines induced efficient as well as reversible male contraception, through different mechanisms: targeting LH receptors inhibited or hyperstimulated Leydig cell testosterone production while targeting FSH receptors did not affect testosterone levels.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8953519     DOI: 10.1016/s0165-0378(96)00991-6

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  2 in total

Review 1.  Milestones in contraceptive vaccines development and hurdles in their application.

Authors:  Satish Kumar Gupta; Abhinav Shrestha; Vidisha Minhas
Journal:  Hum Vaccin Immunother       Date:  2013-11-21       Impact factor: 3.452

Review 2.  Immunocontraception: Filamentous Bacteriophage as a Platform for Vaccine Development.

Authors:  Tatiana I Samoylova; Timothy D Braden; Jennifer A Spencer; Frank F Bartol
Journal:  Curr Med Chem       Date:  2017-11-20       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.